417716-93-9

Basic information

• Product Name: 4-(3-chloro-4-(2-fluoroethylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide
• CAS NO: 417716-93-9
• Molecular Weight: 432.839
• Mol File: 417716-93-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(3-chloro-4-(2-fluoroethylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chloro-4-(2-fluoroethylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide(417716-93-9)
• EPA Substance Registry System: 4-(3-chloro-4-(2-fluoroethylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide(417716-93-9)

Safety Data

• Hazardous Substances Data: 417716-93-9(Hazardous Substances Data)

Upstream product

• 417722-95-3 {4-[(6-carbamoyl-7-methoxy-4-quinolyl)oxy]-2-chlorophenyl}amino-carboxylic acid phenyl ester 
• 460-08-2 2-fluoroethylamine hydrochloride 

Relevant articles and documents

METHOD FOR ASSAY ON THE EFFECT OF VASCULARIZATION INHIBITOR

The present invention provides a method of predicting the antitumor effect of an angiogenesis inhibitor. It is possible to predict the antitumor effect of an angiogenesis inhibitor by evaluating the EGF dependency of a tumor cell for proliferation and/or survival and using the EGF dependency as an indicator. Since the antitumor effect of an angiogenesis inhibitor correlates with the EGF dependency of a tumor cell for proliferation and/or survival, the angiogenesis inhibitors is capable of producing excellent antitumor effect when combined with a substance having EGF inhibitory activity.